Latest news with #Craig-Hallum
Business Insider
2 days ago
- Business
- Business Insider
Centrus Energy (LEU) Gets a Buy from Craig-Hallum
Craig-Hallum analyst Eric Stine maintained a Buy rating on Centrus Energy yesterday. The company's shares closed yesterday at $241.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Stine covers the Industrials sector, focusing on stocks such as NuScale Power, Electrovaya, and Ameresco. According to TipRanks, Stine has an average return of 6.9% and a 37.22% success rate on recommended stocks. In addition to Craig-Hallum, Centrus Energy also received a Buy from Evercore ISI's Nicholas Amicucci in a report issued on July 15. However, on July 21, UBS initiated coverage with a Hold rating on Centrus Energy (NYSE MKT: LEU). LEU market cap is currently $4.13B and has a P/E ratio of 37.79. Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LEU in relation to earlier this year. Last month, KEVIN J HARRILL, the CFO & Treasurer of LEU sold 1,728.00 shares for a total of $217,728.00.
Yahoo
3 days ago
- Business
- Yahoo
Why Are Knowles (KN) Shares Soaring Today
What Happened? Shares of electronic components manufacturer Knowles (NYSE:KN) jumped 10% in the afternoon session after the company reported strong second-quarter financial results that surpassed analyst expectations, driven by a cyclical recovery and robust order growth. The company posted revenue of $146 million, an 8% increase year-over-year, and earnings per share of $0.24, a 20% rise from the prior year's quarter. This performance was driven by a cyclical recovery and robust order growth, particularly in its Precision Devices segment. Management highlighted a strong book-to-bill ratio of 1.15 for the segment, signaling healthy demand. In response to the strong results and positive outlook, analysts at both Baird and Craig-Hallum raised their price targets on the stock to $25 and $22, respectively. Knowles also repurchased $30 million of its shares during the quarter, further bolstering investor sentiment. Is now the time to buy Knowles? Access our full analysis report here, it's free. What Is The Market Telling Us Knowles's shares are not very volatile and have only had 6 moves greater than 5% over the last year. Moves this big are rare for Knowles and indicate this news significantly impacted the market's perception of the business. Knowles is up 1.6% since the beginning of the year, and at $20.33 per share, it is trading close to its 52-week high of $20.58 from January 2025. Investors who bought $1,000 worth of Knowles's shares 5 years ago would now be looking at an investment worth $1,383. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Business
- Yahoo
Intuitive Machines (LUNR) Soars 18.5% on Rosy Prospects from US, China Space Race
We recently published . Intuitive Machines, Inc. (NASDAQ:LUNR) is one of the biggest performers on Wednesday. Intuitive Machines soared by 18.53 percent on Wednesday to end at $13.37 apiece as investors took path from an investment firm's bullish coverage for the company. In a market note, investment bank Craig-Hallum gave a 'buy' recommendation on shares of Intuitive Machines, Inc. (NASDAQ:LUNR) with a price target of $17. The new figure marked a 27-percent upside from its latest closing price. According to Craig-Hallum, Intuitive Machines, Inc. (NASDAQ:LUNR) stands to benefit from the aggressive space race between the United States and China, both of which are targeting to again land humans on the moon by 2030. In other news, Intuitive Machines, Inc.'s (NASDAQ:LUNR) inked a deal with Space Forge for the integration of the latter's semiconductors into its orbital return platform, Zephyr, to support its Earth reentry program. The program is backed by the Texas Space Commission's Space Exploration and Research Fund. Intuitive Machines, Inc. (NASDAQ:LUNR) is scheduled to release the results of its second quarter earnings performance before market open on August 7. While we acknowledge the potential of LUNR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
08-07-2025
- Business
- Yahoo
Performant Healthcare Draws Buy Rating Despite Insider Sell-Off
Performant Healthcare, Inc. (NASDAQ:PHLT) is one of the . Craig-Hallum maintains a Buy rating on the stock following a major stock sale by the company's top executive. A healthcare professional holding a device with innovative technology developed by the medical technology company. Headquartered in Florida, Performant Healthcare, Inc. (NASDAQ:PHLT) is a U.S.-based payment integrity company offering technology-enabled audit, recovery, eligibility, customer care, and analytics services to health plans. With solutions capable of identifying and recovering improper payments and streamlining billing processes, the company serves clients like Medicaid, Medicare Advantage, and commercial insurers. Performant Healthcare, Inc. (NASDAQ:PHLT) reported a 29% increase in revenue in Q1 2025, compared to the same quarter the previous year. The company has also revised its revenue guidance for 2025 from $133 to $135 million, signaling strong confidence in growth prospects. However, in a bold move, Director Lisa Im sold 180,867 shares of the company on June 4, 2025, in a transaction valued at $587,817. Amid this significant change in insider transactions, Craig-Hallum reiterated a Buy rating on the stock, indicating confidence in the company's future growth. With a one-year median stock price forecast of $7, Performant Healthcare, Inc. (NASDAQ:PHLT)'s shares are available for interested investors at a price of $4 as of June 30, 2025. While we acknowledge the potential of PHLT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Low Risk Dividend Paying Stocks for June 2025 and Disclosure. None. Sign in to access your portfolio
Yahoo
03-07-2025
- Business
- Yahoo
Craig-Hallum Initiates Coverage of Butterfly (BFLY) With a Buy Rating
Butterfly Network, Inc. (NYSE:BFLY) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Craig-Hallum analyst Chase Knickerbocker has initiated coverage of Butterfly Network, Inc. (NYSE:BFLY) with a Buy rating and a $3 price target, citing the company's disruptive position in the point-of-care ultrasound market. Butterfly's proprietary technology replaces traditional piezoelectric crystal-based ultrasound components with a chip-based semiconductor platform, allowing for a single probe to handle multiple imaging needs. This innovation not only reduces manufacturing complexity and cost, but also enables rapid software-driven improvements that set Butterfly apart from most handheld competitors. A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the device. The firm's outlook is underpinned by Butterfly's expanding direct-to-consumer (DTC) reach and a growing number of institutional partnerships, including leading health systems and academic centers. These relationships are expected to drive consistent hardware sales while building recurring revenue from software subscriptions. Butterfly Network's technology also places it at the forefront of healthcare's digital transformation. By combining advanced imaging with real-time data interpretation and cloud-based collaboration tools, the company is integrating AI into clinical workflows to enhance diagnostic speed and accuracy. While we acknowledge the potential of BFLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BFLY and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Best Biotech Stocks To Invest In Now and 12 Best Healthcare Stocks to Buy Now. Disclosure: None. Sign in to access your portfolio
